B9T8T0 (B9T8T0_RICCO) Ricinus communis (Castor bean)

Ribosome-inactivating protein UniProtKBInterProSTRINGInteractive Modelling

576 aa; Sequence (Fasta) ; 1 identical sequence: Ricinus communis: P02879

Available Structures

97 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystallographic refinement of ricin to 2.5 Angstroms Heteromer
P02879;
36-576
BGC;NAG;
Assess
Ricin bound to VHH antibody V6E11 Heteromer
P02879;
39-576
NAG;NAG;SO4;EDO;CL;
Assess
Ricin in complex with Fab JB4 Heteromer
P02879;
39-576
NAG;NAG;EDO;CL;SO4;
Assess
Ricin bound to VHH antibody V5G1 Heteromer
P02879;
40-576
NAG;NAG;NAG;ZN;CL;
Assess
Ricin bound to VHH antibody V5G6 Heteromer
P02879;
40-576
NAG;NAG;NAG;ZN;CL;
Assess
Ricin bound to VHH antibody V11B2 Heteromer
P02879;
40-576
NAG;NAG;NAG;ZN;CL;
Assess
Ricin bound to VHH antibody V2C11 Heteromer
P02879;
40-576
NAG;NAG;GAL;EDO;ZN;CL;
Assess
Ricin in complex with Fab SylH3 Heteromer
P02879;
40-576
NDG;NDG;2PE;
Assess
Crystal structure of ricin bound with dinucleotide ApG Heteromer
P02879;
40-576
BGC;NAG;
Assess
Ricin bound to VHH antibody V5E1 Heteromer
P02879;
40-576
NAG;NAG;CL;
Assess
Ricin bound to VHH antibody V5E4 Heteromer
P02879;
41-576
NAG;NAG;EDO;ZN;
Assess
Ricin A chain bound to VHH antibody V6H8 Heteromer
P02879;
38-302
NI;EDO;IMD;
Assess
V5E1-RTA complex Heteromer
P02879;
39-302
CL;EDO;
Assess
Ricin catalytic subunit bound go A9 VHH antibody Heteromer
P02879;
40-302
Assess
Ricin A chain bound to camelid nanobody (VHH4) Heteromer
P02879;
39-301
Assess
Ricin A chain bound to camelid nanobody (VHH1) Heteromer
P02879;
36-296
CL;EDO;
Assess
Ricin A chain bound to camelid nanobody (VHH8) Heteromer
P02879;
39-298
Assess
Single-domain VHH intrabodies neutralize ricin toxin. Heteromer
P02879;
40-298
EDO;CL;
Assess
Crystal structure of the RTA-c10-P2 complex Heteromer
P02879; P05387;
40-298
Assess
Ricin A chain bound to camelid Heteromer
P02879;
40-298
CL;EDO;
Assess
Ricin A chain bound to camelid nanobody (VHH5) Heteromer
P02879;
39-297
CL;
Assess
Single-domain VHH intrabodies neutralize ricin toxin Heteromer
P02879;
40-298
Assess
Ricin A chain bound to VHH antibody V6A7 Heteromer
P02879;
40-298
CL;
Assess
Crystal structure of ricin-A chain in complex with the antibody 6C2 Heteromer
P02879;
40-298
Assess
Ricin A chain bound to camelid nanobody (VHH9)(E1) Heteromer
P02879;
40-298
SO4;
Assess
Ricin A chain bound to camelid nanobody (VHH2)(F5) Heteromer
P02879;
39-296
EDO;ZN;CL;
Assess
Single-domain VHH intrabodies neutralize ricin toxin Heteromer
P02879;
36-293
11×CL;MES;SO4;
Assess
Ricin toxin in complex with neutralizing single chain monoclonal antibodies (VHHs) Heteromer
P02879;
40-297
CL;
Assess
Ricin A chain bound to VHH antibody V6A6 Heteromer
P02879;
40-296
ACY;CA;EDO;
Assess
Ricin A chain bound to VHH antibody V8E6 Heteromer
P02879;
40-296
ZN;CL;
Assess
Ricin A chain bound to VHH antibody V6D4 Heteromer
P02879;
40-296
ZN;CL;IMD;EDO;
Assess
Ricin A chain bound to VHH antibody V2G10 Heteromer
P02879;
40-295
CL;PG4;
Assess
rRNA N-glycosylase RTA Heteromer
P02879; P05387;
41-295
Assess
Ricin A chain bound to camelid nanobody (VHH3) Heteromer
P02879;
40-294
ZN;ACY;CL;EDO;
Assess
RTA-V1C7 Heteromer
P02879;
40-294
PG4;ACY;EDO;CL;
Assess
RTA-V1C7-G29R-no_salt Heteromer
P02879;
40-294
CL;
Assess
RTA-V1C7_G29R-high-salt Heteromer
P02879;
40-294
PO4;CL;EDO;
Assess
Single-domain VHH intrabodies neutralize ricin toxin Heteromer
P02879;
41-294
CL;EDO;
Assess
RTA1-33/44-198 (RVEC) bound to Single Domain Antibody A3C8 Heteromer
P02879;
40-216
SO4;
Assess
Crystal structure of ricin bound with formycin monophosphatehomo-2-mer41-576
BGC;NAG;FMP;
Assess
Ricin A-Chain (Recombinant) E177D Mutanthomo-2-mer40-302
GOL;SO4;
Assess
RICIN A-CHAIN (RECOMBINANT) N122A MUTANThomo-2-mer40-302
ACT;SO4;
Assess
Ricin A-Chain (Recombinant) E177D Mutant with a bound acetatehomo-2-mer40-302
ACT;SO4;
Assess
RICIN A-CHAIN (RECOMBINANT) R213D MUTANThomo-2-mer40-302
SO4;
Assess
RICIN A-CHAIN (RECOMBINANT)homo-2-mer41-298
Assess
RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH ADENOSINE (ADENOSINE BECOMES ADENINE IN THE COMPLEX)homo-2-mer41-298
ADE;
Assess
RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH FORMYCINhomo-2-mer41-298
FMC;
Assess
STRUCTURE OF RICIN A CHAIN MUTANT, COMPLEX WITH AMPhomo-2-mer41-298
AMP;
Assess
STRUCTURE OF RICIN A CHAIN MUTANThomo-2-mer41-297
Assess
RICIN A CHAIN (RECOMBINANT) COMPLEX WITH PTEROIC ACIDmonomer35-302
PT1;
Assess
Structure of Ricin A chain bound with N-(N-(pterin-7-yl)carbonyl-L-serinyl)-L-tryptophanmonomer36-302
19L;SO4;MLA;
Assess
Crystal structure of ricin A chain in complex with inhibitor 9-oxo-4-fluorenecarboxamidemonomer36-302
R6T; 17×EDO; 10×CL;
Assess
Structure of ricin A chain bound with 2-amino-4-oxo-N-(2-(3-phenylureido)ethyl)-3,4-dihydropteridin…monomer36-302
1MX;SO4;MLA;
Assess
THE STRUCTURE OF RECOMBINANT RICIN A CHAIN AT 2.3 ANGSTROMSmonomer36-302
Assess
RICIN A CHAIN (RECOMBINANT) COMPLEX WITH NEOPTERINmonomer36-302
NEO;
Assess
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 9-DEAZAGUANINEmonomer36-302
9DG;
Assess
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 2,5-DIAMINO-4,6-DIHYDROXYPYRIMIDINE (DDP)monomer36-302
DDP;
Assess
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 7-DEAZAGUANINEmonomer36-302
7DG;
Assess
STRUCTURE OF RICIN A CHAIN BOUND WITH INHIBITOR 8-METHYL-9-OXOGUANINEmonomer36-302
MOG;
Assess
Crystal structure of Ricin A chain bound with (S)-2-amino-N-(1-hydroxy-3-phenylpropan-2-yl)-4-oxo-3…monomer40-302
IFX;SO4;
Assess
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-D-tyr…monomer40-302
I9P;SO4;
Assess
Crystal structure of Ricin A chain bound with (S)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami…monomer40-302
IF4;SO4;
Assess
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-D-phe…monomer40-302
IEW;SO4;
Assess
Crystal structure of Ricin A chain bound with N2-(2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)gly…monomer40-302
IWQ;SO4;
Assess
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-L-tyr…monomer40-302
I8T;SO4;
Assess
Structure of Ricin A chain bound with N-(N-(pterin-7-yl)carbonylglycyl)-L-phenylalaninemonomer40-302
RS8;
Assess
Structure of ricin A chain bound with benzyl-(2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxamido)e…monomer40-302
5MX;
Assess
Crystal structure of Ricin A chain bound with (S)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami…monomer40-302
IEZ;SO4;
Assess
Structure of ricin A chain bound with N-(N-(pterin-7-yl)carbonylglycyl)-L-phenylalanyl)-L-phenylala…monomer40-302
19M;SO4;MLA;
Assess
Structure of ricin A chain bound with N-(N-(pterin-7-yl)carbonylglycyl)glycinemonomer40-302
19J;SO4;MLA;
Assess
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)glycyl…monomer41-302
RS8;SO4;
Assess
Ricin A-Chain (Recombinant) at 100Kmonomer41-302
GLC;SO4;
Assess
Structure of Rivax: A Human Ricin Vaccinemonomer41-302
SO4;
Assess
Crystal structure of Ricin A chain bound with N2-(2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)gly…monomer40-300
JKU;SO4;
Assess
Structure of ricin A chain bound with N-((1H-1,2,3-triazol-4-yl)methyl-2-amino-4-oxo-3,4-dihydropte…monomer40-300
0RB;
Assess
Crystal structure of Ricin A chain bound with (R)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami…monomer40-299
IFH;SO4;
Assess
Crystal structure of ricin A chain in complex with 5-mesitylthiophene-2-carboxylic acidmonomer39-298
ZJ7;EDO;SO4;
Assess
Crystal structure of ricin A chain in complex with inhibitor 4-(2-thienylmethyl)benzoic acidmonomer38-297
22×EDO;DMS;R7T;
Assess
Crystal structure of Ricin A chain bound with (S)-2-(2-amino-4-oxo-3,4-dihydropteridine-7-carboxami…monomer40-298
IFQ;SO4;
Assess
Crystal structure of Ricin A chain bound with (2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)-L-phe…monomer40-298
IEK;SO4;
Assess
Crystal structure of Ricin A chain bound with N2-(2-amino-4-oxo-3,4-dihydropteridine-7-carbonyl)gly…monomer40-298
SO4;
Assess
Crystal structure of ricin A chain in complex with inhibitor 5-phenyl-2-thiophenecarboxylic acidmonomer39-297
15×EDO;JMG;DMS;
Assess
Crystal structure of Ricin A-chain in complex with the cyclic tetranucleotide inhibitor, a transiti…monomer40-298
C2X;SO4;
Assess
Crystal Structure of Ricin A chain complexed with Baicalin inhibitormonomer40-298
0XE;
Assess
RTA in complex with 7-carboxy-pterinmonomer39-296
JP2;
Assess
Crystal structure of ricin A chain in complex with 5-(o-tolyl)thiophene-2-carboxylic acidmonomer36-293
ZJA;GOL;
Assess
Ricin a-chain (recombinant) complex with n-methylureamonomer41-298
SO4;NMU;
Assess
RTA in complex with N-(furanylmethyl)-7-carbamoyl-pterinmonomer39-296
JP3;
Assess
Ricin a-chain (recombinant) complex with adeninemonomer41-298
SO4;ADE;
Assess
Ricin A-chain (recombinant) complex with Acetamidemonomer41-298
SO4;ACM;
Assess
Ricin A-chain (recombinant) complex with Ureamonomer41-298
SO4;URE;
Assess
Crystal structure of ricin A chain in complex with 5-(2,6-dimethylphenyl)thiophene-2-carboxylic acidmonomer40-296
ZJ4;EDO;ZN;
Assess
complex of Ricin A chain and pyrimidine-based inhibitormonomer40-296
EJ5;
Assess
Crystal structure of ricin A chain in complex with 5-(2-ethylphenyl)thiophene-2-carboxylic acidmonomer39-294
CL; 18×EDO;ZJD;
Assess
Stabilized Ricin Immunogen 1-33/44-198monomer41-223
SO4;
Assess
Ricin A-chain variant 1-33/44-198 with engineered disulfide bond, R48C/T77C/D75Nmonomer41-223
SO4;
Assess
Ricin A-chain variant 1-33/44-198 with engineered disulfide bondmonomer41-223
SO4;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5ddz.1.Amonomer0.8540-298
100.00
Assess
7kc9.1.Bmonomer0.83317-576
100.00
Assess
6nqt.1.Amonomer0.62369-491
20.69
Assess